Our Story
MiraKind was founded by Dr. Joanne Weidhaas, who co-discovered the KRAS-variant, a unique inherited genetic variant influencing cancer risk. The organization is dedicated to empowering individuals with knowledge about their genetics, focusing on research, education, and access to genetic testing for patients and their families.